Akebia Therapeutics, Inc. AKBA

Healthcare — Drug Manufacturers Specialty & Generic

0.90 (0.02) (2.17%) as of 25 Sep

Market cap: $254.7M
P/E: 0.0×

Follow AKBA

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
Cash and Short Term Investments	260.34	317.79	104.64	147.45	228.70	149.80	90.47	42.93	51.87	184.84
Receivables	33.82	34.22	233.66	39.11	66.85	51.58	40.28	39.29	34.37	47.03
Inventory	—	—	114.25	116.35	61.02	36.63	21.57	15.69	16.24	15.61
Total current assets	296.32	358.36	468.28	309.53	371.44	271.15	185.18	118.15	113.83	252.96
Property, Plant, Equpment (Net)	2.61	3.62	8.02	10.38	8.62	6.75	5.21	3.63	2.20	1.22
Goodwill and Intangible Assets (Total)	—	—	383.21	346.27	199.22	167.17	131.13	95.09	59.04	59.04
Long-term assets (Other)	1.28	2.27	137.04	75.99	37.98	50.42	5.37	12.42	37.38	59.68
Total non-current assets	3.90	5.89	528.27	461.67	272.70	258.20	170.87	123.55	106.84	123.61
Total Assets	300.22	364.25	996.54	771.20	644.14	529.35	356.05	241.70	220.67	376.57
Accounts Payable	2.04	7.00	42.80	39.22	41.31	33.59	18.02	14.64	15.18	21.19
Accrued Expenses	30.26	52.44	150.92	129.07	130.62	109.01	75.78	67.74	63.46	121.72
Current Part of Debt	0.00	—	15.00	5.00	5.00	97.54	32.00	17.50	—	—
Current Revenue (Deferred)	81.97	81.67	56.98	39.83	15.21	20.91	3.74	0.00	0.00	2.68
Other current liabilities	114.00	133.00	208.00	164.00	141.00	125.00	75.00	—	2.27	17.36
Total current liabilities	114.27	141.11	265.69	208.12	187.15	261.05	129.54	99.87	80.91	162.94
Long Term Debt (Total)	0.00	—	—	75.81	96.38	87.00	34.08	17.18	38.69	48.25
Non-current Revenue (Deferred)	117.80	100.55	58.72	33.12	25.35	21.47	43.30	43.30	—	—
Long Term Tax Liability (Deferred)	—	—	6.63	(6.63)	—	—	—	—	—	—
Non-current Liabilities (Other)	0.03	0.02	29.57	31.87	63.03	139.11	114.95	102.99	146.70	132.77
Total non-current liabilities	117.83	100.57	94.92	168.33	209.38	194.29	221.29	172.42	188.94	181.02
Total liabilities	232.10	241.67	360.61	376.44	396.52	455.34	350.82	272.29	269.86	343.96
Additional Paid In Capital	365.30	493.82	1,150.58	1,188.81	1,425.12	1,536.80	1,562.25	1,578.36	1,629.17	1,716.31
Common Stock (Net)	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	(297.14)	(370.81)	(514.39)	(794.05)	(1,177.51)	(1,462.80)	(1,557.02)	(1,608.95)	(1,678.36)	(1,683.70)
Common Equity (Total)	68.12	122.57	635.93	394.76	247.62	74.01	5.23	(30.58)	(49.18)	32.61
Shareholders Equity (Total)	68.12	122.57	635.93	394.76	247.62	74.01	5.23	(30.58)	(49.18)	32.61
Shareholders Equity and Liabilities (Total)	300.22	364.25	996.54	771.20	644.14	529.35	356.05	241.70	220.67	376.57
Shares (Common)	38.62	47.61	116.89	121.68	148.07	177.00	184.14	194.58	224.85	265.43
Shareholders Equity (Tangible)	68.12	122.57	252.72	48.49	48.40	(93.16)	(125.90)	(125.67)	(108.23)	(26.43)
Net Debt	(260.34)	(317.79)	(89.64)	(66.64)	(127.32)	34.74	(24.39)	(8.24)	(13.18)	(136.59)
Total Debt	0.00	—	15.00	80.81	101.38	184.54	66.08	34.68	38.69	48.25

Fold the line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Akebia Therapeutics, Inc. AKBA